Oramed to Present at the Disruptive Growth Showcase Conference
JERUSALEM, Sept. 25, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming 2017 Disruptive Growth Company Showcase NYC Conference, taking place September 27, 2017 in New York City. Nadav Kidron, Oramed’s CEO, […]
